泌尿器領域　画像診断の勘ドコロNEO

01 腎

P.4 掲載の参考文献

1. Thornton FJ, et al. Helical CT evaluation of the perirenal space and its boundaries : a cadaveric study. Radiology 2001 ; 218 : 659-63.

PubMed

2. 竹口隆也, ほか. 後腹膜腔のCT解剖. 画像診断 2011 ; 31 : 1130-40.

Medical*Online

3. Raptopoulos V, et al. Why perirenal disease does not extend into the pelvis : the importance of closure of the cone of the renal fasciae. AJR Am J Roentgenol 1995 ; 164 : 1179-84.

 

P.5 掲載の参考文献

1. 日本医学放射線学会, 編. 画像診断ガイドライン 2016年版. 金原出版, 東京, 2016, p456-8.

 

2. Silverman SG, et al. Bosniak classification of cystic renal masses, version 2019 : An update proposal and needs assessment. Radiology 2019 ; 292 : 475-88.

PubMed

3. Israel GM, et al. Evaluation of cystic renal masses : comparison of CT and MR imaging by using the Bosniak classification system. Radiology 2004 ; 231 : 365-71.

 

P.7 掲載の参考文献

4. Tickoo SK, et al. Spectrum of epithelial neoplasms in end-stage renal disease : an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006 ; 30 : 141-53.

PubMed

P.8 掲載の参考文献

1. 日本医学放射線学会, ほか編. 画像診断ガイドライン, 2016年版, 金原出版, 東京, 2016, p459-61.

 

2. Sasaguri K, et al. CT and MR imaging for solid renal mass characterization. Eur J Radiol 2018 ; 99 : 40-54.

 

P.10 掲載の参考文献

2. He J, et al. Dynamic computed tomographic features of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions : comparison with clear cell renal cell carcinoma. J Comput Assist Tomgr 2015 ; 39 : 730-6.

 

3. Woo S, et al. MDCT findings of renal cell carcinoma associated with Xp 11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma. AJR Am J Roentgenol 2015 ; 204 : 542-9.

 

3. Kim JI, et al. Segmental enhancement inversion at biphasic multidete tor CT : characteristic finding of small renal oncocytoma. Radiology 2009 ; 252 : 441-8.

 

4. Liu K, et al. Renal carcinomas associated with Xpll.2 translocations/ TFE3 gene fusions : findings on MRI and computed tomography imaging. J Magn Reson Imaging 2014 ; 40 : 440-7.

 

4. Schieda N, et al. Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT : systematic review. Eur Radiol 2014 ; 24 : 1421-9.

PubMed

P.12 掲載の参考文献

1. Nagashima Y, et al. Transition of organizational category on renal cancer. Jpn J Clin Onco1 2013 ; 43 : 233-42.

 

P.13 掲載の参考文献

5. Prasad SR, et al. Common and uncommon histologic subtypes of renal cell carcinoma : imaging spectrum with pathologic correlation. RadioGraphics 2006 ; 26 : 1795-806.

PubMed

P.14 掲載の参考文献

6. Kenney PA, et al. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney : a detailed study of radiological, pathological and clinical outcomes. BJU Int 2015 ; 116 : 85-92.

PubMed

7. Cornelis F, et al. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review. Eur Radiol 2017 ; 27 : 1087-95.

 

8. Cornelis F, et al. Tubulocystic renal cell carcicnoma : a new radiological entity. Eur Radiol 2016 ; 26 : 1108-15.

PubMed

P.15 掲載の参考文献

1. Jinzaki M, et al. Renal anglomyolipoma : a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 2014 ; 39 : 588-604.

 

2. Prando A, et al. Renal cell carcinoma : unusual imaging manifestations. Radiographics 2006 ; 26 : 233-44.

PubMed

P.16 掲載の参考文献

3. Rosenkrantz AB, et al. Angiomyolipoma with epithelial cysts : mimic of renal cell carcinoma. Clin Imaging 2010 ; 34 : 65-8.

PubMed

P.18 掲載の参考文献

4. Tsukada J, et al. Epithelioid angiomyolipoma of the kidney : radiological imaging. Int J Urol 2013 ; 20 : 1105-11.

PubMed

5. Kaneko K, et al. Renal epithelioid angiomyolipoma : Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol 2020 ; 27 : 599-604.

 

P.19 掲載の参考文献

6. Zhou M, et al : Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entily : molecular and histologic evidence. Am J Surg Pathol 2009 ; 33 : 72-80.

 

7. Suzuki T, et al. Radiologic features of mixed epithelial and stromal tumors of the kidney : Hyperattenuating on unenhanced computed tomography and T2-hypointensity on magnetic resonance imaging. Radiol Case Rep 2021 ; 16 : 858-62.

 

8. Wood CG 3rd, et al. CT and MR imaging for evaluation of cystic renal lesions and diseases. Radiographics 2015 ; 35 : 125-41.

 

9. Schnell P, et al. Complex renal cysts associated with crizotinib treatment. Cancer Med 2015 ; 4 : 887-96.

PubMed

P.20 掲載の参考文献

1. 日本泌尿器科学会, ほか編. 腎癌取扱い規約, 第4版. 金原出版, 東京, 2011.

 

2. Kresowik TP, et al. Combined renal sinus fat and perinephric fat renal cell carcinoma invasion has a worse prognosis than either alone. J Urol 2010 ; 184 : 48-52.

 

3. Kim C, et al. Diagnostic value of multidetector computed tomography for renal sinus fat invasion in renal cell carcinoma patients. Eur J Radiol 2014 ; 83 : 914-8.

PubMed

4. Sokhi HK, et al. Stage T3a renal cell carcinoma : staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion. Br J Radiol 2015 ; 88 : 20140504.

PubMed

5. Bolster F, et al. Renal cell carcinoma : Accuracy of multidetector computed tomography in the assessment of renal sinus fat invasion. J Comput Assist Tomogr 2016 ; 40 : 851-5.

PubMed

6. 立入哲也, ほか. Usefulness of macroscopic classification in pT3a renal cell carcinoma : RSNA 2019 GU233-SD-MOB4 (会議録) http://archive.rsna.org/2019/subspecialty/GenitourinaryRadiology.pdf

 

P.21 掲載の参考文献

7. 日本泌尿器科学会, 編 : 腎癌診療ガイドライン 2017年版. メディカルレビュー社, 大阪, 2017.

 

P.25 掲載の参考文献

1. 日本医学放射線学会, 編. (7) 泌尿器. 画像診断ガイドライン 2016年版. 金原出版, 東京, 2016, p439-92.

 

2. Craig WD, et al. Pyelonephritis : radiologic-pathologic review. Radiographics 2008 ; 28 : 255-77.

PubMed

3. De Pascale A, et al. Diffusion-weighted magnetic resonance imaging : New perspectives in the diagnostic pathway of non-complicated acute pyelonephritis. Eur Radiol 2013 ; 23 : 3077-86.

PubMed

P.27 掲載の参考文献

4. 井上武夫, ほか. 肺外結核患者の疫学的意義. 結核 2011 ; 86 : 493-8.

Medical*Online

5. Gaudiano C, et al. Multidetector CT urography in urogenital tuberculosis : use of reformatted images for the assessment of the radiological findings. A pictorial essay. Abdom Radiol 2017 ; 42 : 2314-24.

PubMed

6. Senes AT, et al. Granulomatous renal masses following intravesical bacillus Calmette-Guerin therapy : the central unaffected calyx sign. Br J Radiol 2007 ; 80 : e230-3.

PubMed

P.28 掲載の参考文献

1. Gupta S, et al. Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol 2015 ; 204 : 1031-41.

PubMed

2. Ganeshan D, et al. Tumors in von Hippel-Lindau syndrome : From head to toe-comprehensive state-of-the-art review. Radiographics 2018 ; 38 : 849-66.

PubMed

3. 日本泌尿器科学会・日本結節性硬化症学会, 編. 結節性硬化症に伴う腎血管筋脂肪腫診療ガイドライン 2016年版. 金原出版, 東京, 2016.

 

P.30 掲載の参考文献

4. 川野充弘, ほか, IgG4関連腎臓病ワーキンググループ報告. IgG4関連腎臓病診療指針. 日腎会誌 2011 ; 53 : 1062-73.

 

5. Antunes C, et al. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease : CT, MR and PET imaging findings. Insights Imaging 2014 ; 5 : 473-82.

PubMed

P.31 掲載の参考文献

6. Sheth S, et al. Imaging of renal lymphoma : patterns of disease with pathologic correlation. Radiographics 2006 ; 26 : 1151-68.

PubMed

P.32 掲載の参考文献

1. Volpe A, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 2012 ; 62 : 491-504.

PubMed

2. Donat SM, et al. Follow-up for clinically localized renal neoplasms : AUA guideline. J Urol 2013 ; 190 : 407-16.

PubMed

3. Herts BR, et al. Management of the incidental renal mass on CT : A white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2018 ; 15 : 264-73.

 

4. Ljungberg B, et al. European Association of Urology guidelines on renal cell carcinoma : The 2019 update. Eur Urol 2019 ; 75 : 799-810.

PubMed

P.34 掲載の参考文献

5. Walraven M, et al. Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations : a case report and literature review. Angiogenesis 2011 ; 14 : 135-41.

PubMed

6. Fecher LA, et al. Ipilimumab and its toxicities : a multidisciplinary approach. Oncologist 2013 ; 18 : 733-43.

PubMed

02 副腎

P.36 掲載の参考文献

1. Connolly MJ, et al. Diagnostic accuracy of virtual non-contrast enhanced dual-energy CT for diagnosis of adrenal adenoma : a systematic review and meta-analysis. Eur Radiol 2017 ; 27 : 4324-35.

PubMed

P.37 掲載の参考文献

2. Platzek I, et al. Chemical shift imaging for evaluation of adrenal masses : a systematic review and meta-analysis. Eur Radiol 2019 ; 29 : 806-17.

PubMed

P.38 掲載の参考文献

3. Mayo-Smith WW, et al. Management of incidental adrenal masses : A white paper of the ACR incidental findings committee. J Am Coll Radial 2017 ; 14 : 1038-44.

 

P.39 掲載の参考文献

中村保宏, ほか. 第2部 病理学的事項 : 日本泌尿器科学会, ほか編. 副腎腫瘍取扱い規約 2015年3月 第3版. 金原出版, 東京, 2015.

 

笹野公伸. 副腎皮質癌及び二次性悪性腫瘍 : 腫瘍病理鑑別診断アトラス NET・下垂体・副甲状腺・副腎. 文光堂, 東京, 2017.

 

P.40 掲載の参考文献

1. Lloyd RV, et al (eds). WHO Classification of Tumours of Endocrine Organs, 4th ed. IARC Publications, Lyon, 2017.

 

2. Weiss LM, et al. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989 ; 13 : 202-6.

PubMed

P.41 掲載の参考文献

3. Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasm : a clinicopathological and immunophenotypic study of 100 cases. Am J Surg Pathol 2002 ; 26 : 551-66.

PubMed

P.43 掲載の参考文献

1. 日本内分泌学会, ほか編. 日本内分泌学会臨床重要課題「わが国の原発性アルドステロン症の診療に関するコンセンサス・ステートメント」. 日本内分泌学会雑誌 2016 ; 92 : 17-32.

 

2. 日本内分泌学会, 編. 内分泌代謝科専門医研修ガイドブック. 診断と治療社, 東京, 2018, p400-4.

 

P.44 掲載の参考文献

3. 日本内分泌学会, ほか編. 日本内分泌学会臨床重要課題「副腎性サブクリニカルクッシング症候群 新診断基準」の作成と解説. 日本内分泌学会雑誌 2017 ; 93 ; 1-18.

 

P.45 掲載の参考文献

4. 日本内分泌学会, ほか編. 褐色細胞腫・パラガングリオーマ診療ガイドライン 2018. 内分泌学会雑誌 2018 ; 94 : 2-10.

 

5. 日本泌尿器科学会, ほか編. 副腎腫瘍取扱い規約 第3版. 金原出版, 東京, 2015, p19-21.

 

6. 日本泌尿器科学会, ほか編. 副腎腫瘍取扱い規約 第3版. 金原出版, 東京, 2015, p77-83.

 

P.47 掲載の参考文献

村山貞之, ほか. CQ149 泌尿器. 画像診断ガイドライン 2016年版. 日本医学放射線学会, 編. 金原出版, 東京, 2016, p490-1.

 

P.49 掲載の参考文献

1. Boland GW, et al. Incidental adrenal lesion : principles, techniques, and algorithms for imaging characterization. Radiology 2008 ; 249 : 756-75.

PubMed

2. American College of Radiology. ACR appropriateness criteria : incidentally discovered adrenal mass. 2012. http://www.acr.org

 

P.50 掲載の参考文献

3. Brady MJ, et al. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer : a proposal for an efficient diagnostic algorithm. Radiology 2009 ; 250 : 523-30.

PubMed

P.51 掲載の参考文献

1. Vincent JM, et al. The size of normal adrenal glands on computed tomography. Clin Radiol 1994 ; 49 : 453-5.

PubMed

山下康行, ほか. 画像診断 別冊KEYBOOKシリーズ 知っておきたい泌尿器のCT・MRI 改訂第2版. 学研メディカル秀潤社, 東京, 2019, p494-567.

 

P.52 掲載の参考文献

2. Doppman JL, et al. Adrenocorticotropin independent macronodular adrenal hyperplasia : an uncommon cause of primary adrenal hypercortisolism. Radiology 2000 ; 216 : 797-802.

PubMed

3. Carney JA, et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Bartimore) 1985 ; 64 : 270-83.

PubMed

P.53 掲載の参考文献

4. Blake MA, et al. Pheochromocytoma : an imaging chameleon. Radiographics 2004 ; 24 : 87-99.

 

P.54 掲載の参考文献

5. Bharwani N, et al. Adrenocortical carcinoma : the range of appearances on CT and MRI. AJR Am J Roentgenol 2011 ; 196 : 706-14.

 

P.56 掲載の参考文献

6. Rao P, et al. Imaging and pathologic features of myelolipoma. Radiographics 1997 ; 17 : 1373-85.

PubMed

7. Lam KY, et al. A crinical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endoclinol 2001 ; 54 : 633-9.

 

P.57 掲載の参考文献

8. Rozenblit AM, et al. Adrenal histoplasmosis manifested as Addison's disease : unusual CT features with magnetic resonance imaging correlation. Clin Radiol 2001 ; 56 : 682-4.

PubMed

P.60 掲載の参考文献

1. Young WF, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004 ; 136 : 1227-35.

PubMed

2. Rossi GP, et al. Adrenal vein sampling for primary aldosteronism : the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008 ; 26 : 989-97.

PubMed

3. Satoh F, et al. Localization of aldosterone-producing adrenocortical adenomas : significance of adrenal venous sampling. Hypertens Res 2007 ; 30 : 1083-95.

PubMed

4. 日本内分泌学会, ほか編. 日本内分泌学会臨床重要課題「わが国の原発性アルドステロン症の診療に関するコンセンサス・ステートメント」. 日本内分泌学会雑誌 2016 ; 92 : 17-32.

 

P.61 掲載の参考文献

1. 田中正利, ほか. 日本泌尿器内視鏡学会, 編. 泌尿器腹腔鏡手術ガイドライン 2014年版. Jpn J Endourol 2014 ; 27 : 1-46.

 

03 尿路上皮 ( 腎盂・尿管・膀胱 ) : 尿路上皮癌

P.66 掲載の参考文献

1. Jinzaki M, et al. Comparison of CT urography and excretory urography in the detection and localization of urothelial carcinoma of the upper urinary tract. AJR Am J Roentgenol 2011 ; 196 : 1102-9.

PubMed

2. Van Der Molen AJ, et al. CT urography : definition, indications and techniques. A guideline for clinical practice. Eur Radio 2008 ; 18 : 4-17.

 

P.68 掲載の参考文献

3. Cowan NC. CT urography for hematuria. Nat Rev Urol 2012 ; 9 : 218-26.

PubMed

4. Potenta SE, et al. CT urography for evaluation of the ureter. Radiographics 2015 ; 35 : 709-26.

PubMed

5. Takeuchi M, et al. Split-bolus CT-urography using dual-energy CT : feasibility, image quality and dose reduction. Eur J Radiol 2012 ; 81 : 3160-5.

PubMed

P.69 掲載の参考文献

6. Kim JK, et al. Bladder cancer : analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 2004 ; 231 : 725-31.

PubMed

7. Jinzaki M, et al. Detection of bladder tumors with dynamic contrast-enhanced MDCT. AJR Am J Roentgenol 2007 ; 188 : 913-8.

PubMed

8. 日本医学放射線学会, 編. 画像診断ガイドライン 2016年版. 金原出版, 東京, 2016.

 

9. Sudah M, et al. Comprehensive MR urography protocol : Equally good diagnostic performance and enhanced visibility of the upper urinary tract compared to triple-phase CT urography. PLoS One 2016 ; 11 : e0158673, 2016.

PubMed

10. Razavi SA, et al. Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy : a critically appraised topic. Acad Radiol 2012 ; 19 : 1134-40.

 

11. Panebianco V, et al. Multiparametric magnetic resonance imaging for bladder cancer : Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018 ; 74 : 294-306.

 

12. Akita H, et al. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI. AJR Am J Roentgenol 2011 ; 197 : 1130-6.

PubMed

P.74 掲載の参考文献

13. Girard A, et al. Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer. Eur Radiol 2019 ; 29 : 4286-93

 

P.75 掲載の参考文献

1. 日本泌尿器科学会, 編. 膀胱癌診療ガイドライン, 2019年版. 医学図書出版, 東京, 2019.

 

2. 日本泌尿器科学会, 編. 腎盂・尿管癌診療ガイドライン, 2014年版. メディカルレビュー社, 大阪, 2014.

 

3. Huang D, et al. Systematic review : An update on the spectrum of urological malignancies in Lynch syndrome. Bladder Cancer 2018 ; 4 : 261-8.

PubMed

4. Babjuk M, et al. European Association of Urology guidelines on non-muscleinvasive bladder cancer (TaT1 and carcinoma in situ) -2019 update. Eur Urol 2019 ; 76 : 639-57.

 

5. Woo S, et al. Diagnostic performance of MRI for prediction of muscleinvasiveness of bladder cancer : A systematic review and meta-analysis. Eur J Radiol 2017 ; 95 : 46-55.

PubMed

6. Huang L, et al. The diagnostic value of MR imaging in differentiating T staging of bladder cancer : A meta-analysis. Radiology 2018 ; 286 : 502-11.

PubMed

7. Witjes JA, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer : Summary of the 2020 Guidelines. Eur Urol 2021 ; 79 : 82-104.

PubMed

P.76 掲載の参考文献

8. Jinzaki M, et al. Comparison of CT urography and excretory urography in the detection and localization of urothelial carcinoma of the upper urinary tract. AJR Am J Roentgenol 2011 ; 196 : 1102-9.

PubMed

9. Wang LJ, et al. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 2010 ; 183 : 48-55.

PubMed

10. Roupret M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma : 2017 update. Eur Urol 2017 ; 73 : 111-22.

PubMed

P.78 掲載の参考文献

1. Horie S, et al. Japanese guidelines of the management of hematuria 2013. Clin Exp Nephrol 2014 ; 18 : 679-89.

PubMed

2. Kirkali Z, et al. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003 ; 47 : 155-69.

PubMed

3. Caoili EM, et al. CT urography in evaluation of urothelial tumors of the kidney. Abdom Radiol (NY) 2016 ; 41 : 1100-7.

PubMed

4. Vikram R, et al. Imaging and staging of transitional cell carcinoma : part 2, upper urinary tract. AJR Am J Roentgenol 2009 ; 192 : 1488-93.

PubMed

5. Browne RF, et al. Transitional cell carcinoma of the upper urinary tract : spectrum of imaging findings. Radiographics 2005 ; 25 : 1609-27.

PubMed

6. Wong-You-Cheong JJ, et al. Transitional cell carcinoma of the urinary tract : radiologic-pathologic correlation. Radiographics 1998 ; 18 : 123-42 ; quiz 148.

PubMed

P.79 掲載の参考文献

7. Gandhi KR, et al. Revisiting the morphology of pelvicalyceal system in human cadaveric kidneys with a systematic review of literature. Asian J Urol 2019 ; 6 : 249-55.

PubMed

P.80 掲載の参考文献

8. 日本泌尿器科学会, ほか編. 泌尿器科・病理・放射線科 腎盂・尿管・膀胱癌取扱い規約, 第1版. 金原出版, 東京, 2011.

 

9. Shampain KL, et al. Benign diseases of the urinary tract at CT and CT urography. Abdom Radiol (NY) 2019 ; 44 : 3811-26.

PubMed

P.84 掲載の参考文献

10. Chlapoutakis K, et al. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria : Systematic review and meta-analysis. Eur J Radiol 2010 ; 73 : 334-8.

PubMed

P.85 掲載の参考文献

1. 日本泌尿器科学会/日本病理学会/日本医学放射線学会, 編. 腎盂・尿管・膀胱癌取扱い規約, 第1版. 金原出版, 東京, 2011.

 

2. Honda Y, et al. Clinical staging of upper urinary tract urothelial carcinoma for T staging : Review and pictorial essay. Int J Urol 2019 ; 26 : 1024-32.

 

P.86 掲載の参考文献

3. Ito Y, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol 2011 ; 185 : 1621-6.

PubMed

4. Jinzaki M, et al : Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. Int J Urol 2016 ; 23 : 284-98.

PubMed

P.87 掲載の参考文献

5. Akita H, et al : Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI. AJR Am J Roentgenol 2011 ; 197 : 1130-6.

PubMed

6. Obuchi M, et al. Gadolinium-enhanced fat-suppressed T1-weighted imaging for staging ureteral carcinoma : correlation with histopathology. AJR Am J Roentgenol 2007 ; 188 : W256-61.

PubMed

P.88 掲載の参考文献

1. 日本医学放射線学会, 編. 画像診断ガイドライン, 2016年版 第2版. 金原出版, 東京, 2016.

 

2. Tuncbilek N, et al. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer. AJR Am J Roentgenol 2009 ; 192 : 949-55.

PubMed

P.90 掲載の参考文献

3. Takeuchi M, et al. MR imaging of urinary bladder cancer for T-staging : a review and a pictorial essay of diffusion-weighted imaging. J Magn Reson Imaging 2013 ; 38 : 1299-309.

 

4. Takeuchi M, et al. Urinary bladder cancer : diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009 ; 251 : 112-21.

PubMed

5. Hayashi N, et al. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil : a comparison with ultrasonography. BJU Int 2000 ; 85 : 32-6.

 

P.91 掲載の参考文献

6. Panebianco V, et al. Multiparametric magnetic resonance imaging for bladder cancer : Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018 ; 74 : 294-306.

 

P.92 掲載の参考文献

7. Wang HJ, et al. Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carcinoma. AJR Am J Roentgenol 2016 ; 207 : 797-803.

PubMed

P.95 掲載の参考文献

8. Fujii S, et al. Peritumoral enhancement in endometrial cancer on dynamic contrast-enhanced imaging : radiologic-pathologic correlation. J Obstet Gynaecol Res 2014 ; 40 : 1445-9.

PubMed

P.96 掲載の参考文献

9. Barchetti G, et al. Multiparametric MRI of the bladder : inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. Eur Radiol 2019 ; 29 : 5498-506.

 

10. Ueno Y, et al. Diagnostic accuracy and interobserver agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer : A Multireader Validation Study. Eur Urol 2019 ; 76 : 54-6.

PubMed

11. Wang H, et al. Multiparametric MRI for bladder cancer : Validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 2019 ; 291 : 668-74.

PubMed

12. Kim SH. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor. Abdom Radiol (NY) 2020 ; 45 : 491-8.

PubMed

13. 日本泌尿器科学会, ほか編. 泌尿器科・病理・放射線科 腎盂・尿管・膀胱癌取扱い規約, 第1版. 金原出版, 東京, 2011.

 

P.98 掲載の参考文献

1. 日本泌尿器科学会/日本病理学会/日本医学放射線学会, 編. 腎盂・尿管・膀胱癌取扱い規約, 第1版. 金原出版, 東京, 2011.

 

2. Pano B, et al. Pathways of lymphatic spread in male urogenital pelvic malignancies. Radiographics 2011 ; 31 : 135-60.

PubMed

3. Roth B, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010 ; 57 : 205-11.

 

4. Shinagare AB, et al. Surveillance of patients with bladder cancer following cystectomy : yield of CT urography. Abdom Imaging 2013 ; 38 : 1415-21.

 

5. Horn T, et al. Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int 2016 ; 96 : 51-6.

PubMed

6. Girard A, et al : Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer. Eur Radiol 2019 ; 29 : 4286-93.

PubMed

7. Woo S, et al. The diagnostic performance of MRI for detection of lymph node metastasis in bladder and prostate cancer : An updated systematic review and diagnostic meta-analysis. AJR Am J Roentgenol 2018 ; 210 : W95-109.

PubMed

8. Li Y, et al. Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer. Chin J Cancer 2018 ; 37 : 3.

PubMed

Shankar PR, et al. A pictorial review of bladder cancer nodal metastases. Transl Androl Urol 2018 ; 7 : 804-13.

PubMed

P.101 掲載の参考文献

9. Matin SF, et al. Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates. J Urol 2015 ; 194 : 1567-74.

PubMed

10. Dominguez-Escrig JL, et al. Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma : A systematic review by the European Association of Urology guidelines panel on non-muscle-invasive bladder cancer. Eur Urol Focus 2019 ; 5 : 224-41.

PubMed

11. Scolieri MJ, et al. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 2000 ; 56 : 930-4.

PubMed

12. Voskuilen CS, et al. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma. Eur Urol Oncol 2020 ; 3 : 73-9.

PubMed

13. Shinagare AB, et al. Metastatic pattern of bladder cancer : correlation with the characteristics of the primary tumor. AJR Am J Roentgenol 2011 ; 196 : 117-22.

PubMed

P.103 掲載の参考文献

14. Shankar PR, et al. A pictorial review of bladder cancer nodal metastases. Transl Androl Urol 2018 ; 7 : 804-13.

PubMed

P.104 掲載の参考文献

1. 日本泌尿器科学会, 編. 膀胱癌診療ガイドライン, 2019年版. 医学図書出版, 東京, 2019.

 

2. Barentsz JO, et al. Staging urinary bladder cancer after transurethral biopsy : value of fast dynamic contrast-enhanced MR imaging. Radiology 1996 ; 201 : 185-93.

PubMed

3. Green DB, et al. Complications of intravesical BCG immunotherapy for bladder cancer. Radiographics 2019 ; 39 : 80-94.

PubMed

Moomjian LN, et al. Follow the stream : Imaging of urinary diversions. Radiographics 2016 ; 36 : 688-709.

PubMed

P.106 掲載の参考文献

4. Kawamoto S, et al. Role of CT in postoperative evaluation of patients undergoing urinary diversion. AJR Am J Roentgenol 2010 ; 194 : 690-6.

PubMed

P.109 掲載の参考文献

5. Soukup V, et al. Follow-up after surgical treatment of bladder cancer : a critical analysis of the literature. Eur Urol 2012 ; 62 : 290-302.

PubMed

6. Huguet J. Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors. Actas Urol Esp 2013 ; 37 : 376-82.

PubMed

7. Picozzi S, et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer : a meta-analysis on 13,185 patients. J Urol 2012 ; 188 : 2046-54.

 

P.110 掲載の参考文献

8. Nieuwenhuijzen JA, et al. Follow-up after cystectomy : regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy. Eur J Surg Oncol 2014 ; 40 : 1677-85.

PubMed

9. Donat SM. Staged based directed surveillance of invasive bladder cancer following radical cystectomy : valuable and effective? World J Urol 2006 ; 24 : 557-64.

PubMed

04 前立腺

P.112 掲載の参考文献

1. Ullrich T, et al. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol 2018 ; 28 : 17-23.

PubMed

2. Slough RA, et al. Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality. Clin Radiol 2018 ; 73 : 216. e9-216. e14.

 

3. Tamada T, et al. Early experience with MRI-ultrasound fusion-guided prostate biopsy in Japanese men with elevated PSA levels. Magn Reson Med Sci 2019 ; 18 : 301-3.

PubMed

4. Tanaka U, et al. Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer : comparison with conventional two- and three-dimensional T2-weighted turbo spin-echo imaging. Jpn J Radiol 2017 ; 35 : 707-17.

PubMed

5. Ream JM, et al. Dynamic contrast-enhanced MRI of the prostate : An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer. J Magn Reson Imaging 2017 ; 45 : 1464-75.

PubMed

P.113 掲載の参考文献

6. Turkbey B, et al. Prostate imaging reporting and data system version 2.1 : 2019 update of prostate imaging reporting and data system version 2. Eur Urol 2019 ; 76 : 340-51.

PubMed

7. Tamada T, et al. High b value (2,000sec/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla : comparison with 1,000sec/mm2 for tumor conspicuity and discrimination of aggressiveness. PLoS One 2014 ; 9 : e96619.

 

8. Ueno YR, et al. Computed diffusion-weighted imaging in prostate cancer : Basics, advantages, cautions, and future prospects. Korean J Radiol 2018 ; 19 : 832-7.

 

9. Tamada T, et al. Prostate cancer : Diffusion-weighted MR imaging for detection and assessment of aggressiveness-comparison between conventional and kurtosis models. Radiology 2017 ; 284 : 100-8.

PubMed

10. Shan Y, et al. Prostate cancer aggressive prediction : preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology. Abdom Radiol (NY) 2019 ; 44 : 3441-52.

 

11. Liu W, et al. Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma. J Magn Reson Imaging 2018 ; 48 : 491-8.

PubMed

P.114 掲載の参考文献

1. McNeal JE. The zonal anatomy of the prostate. Prostate 1981 ; 2 : 35-49.

PubMed

2. Weinreb JC, et al. PI-RADS prostate imaging reporting and data system : 2015, version 2. Eur Urol 2016 ; 69 : 16-40.

 

P.116 掲載の参考文献

1. Epstein JI, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma : Definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016 ; 40 : 244-52.

PubMed

2. van Leenders GJLH, et al. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol 2020 ; 44 : e87-e99.

PubMed

P.117 掲載の参考文献

3. Ohori M, et al. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 1994 ; 152 : 1714-20.

PubMed

4. Epstein JI, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994 ; 271 : 368-74.

PubMed

P.118 掲載の参考文献

5. Takahashi H, et al. Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan. Prostate 2014 ; 74 : 321-5.

PubMed

6. Kluth LA, et al. Pathologic nodal staging scores in patients treated with radical prostatectomy : a postoperative decision tool. Eur Urol 2014 ; 66 : 439-46.

PubMed

7. Naito S, et al. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading : data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 2008 ; 180 : 904-9 ; discussion 9-10.

 

P.120 掲載の参考文献

1. 全国がんセンター協議会ホームページ : 全がん協生存率調査, 全施設生存率より. http://www.zengankyo.ncc.go.jp/etc/

 

2. 日本泌尿器科学会, 編. 前立腺癌診療ガイドライン 2016年版. メディカルレビュー社, 大阪, 2016, p97-182.

 

P.122 掲載の参考文献

3. Bolla M, et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk : 10-year results of an EORTC randomised study. Lancet Oncol 2010 ; 11 : 1066-73.

 

P.124 掲載の参考文献

4. Smith MR, et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med 2018 ; 378 : 1408-18.

PubMed

5. Hussain M, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med 2018 ; 378 : 2465-74.

PubMed

6. Fizazi K, et al. Darolutamide in nonmetastatic, castration-resistant prostate cancer. N Engl J Med 2019 ; 380 : 1235-46.

PubMed

7. Gillessen S, et al. Management of patients with advanced prostate cancer : The report of the advanced prostate cancer consensus conference APCCC 2017. Eur Urol 2018 ; 73 : 178-211.

 

8. Fendler WP, et al. Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer. Clin Cancer Res 2019 ; 25 : 7448-54.

PubMed

9. Parker CC, et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE) : a randomised controlled phase 3 trial. Lancet 2018 ; 392 : 2353-66.

 

P.125 掲載の参考文献

1. Ayala AG, et al. The prostatic capsule : does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 1989 ; 13 : 21-7.

PubMed

2. de Rooij M, et al. Accuracy of magnetic resonance imaging for local staging of prostate cancer : a diagnostic meta-analysis. Eur Urol 2016 ; 70 : 233-45.

PubMed

3. Mehralivand S, et al. A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI. Radiology 2019 ; 290 : 709-19.

PubMed

4. Cheng L, et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 1999 ; 86 : 1775-82.

PubMed

P.126 掲載の参考文献

5. Feng TS, et al. Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer. Urol Oncol 2015 ; 33 : 109. e15-22.

 

6. Rosenkrantz AB, et al. Radiologist, be aware : ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 2014 ; 202 : 109-20.

PubMed

P.128 掲載の参考文献

7. Tamada T, et al. Value of preoperative 3T multi-parametric MRI for surgical margin status in patients with prostate cancer. J Magn Reson Imaging 2016 ; 44 : 584-93.

PubMed

P.129 掲載の参考文献

8. Zhang F, et al. Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer : A systematic review and meta-analysis. Br J Radiol 2019 ; 92 : 20190480.

PubMed

9. Rayn KN, et al. Added value of multiparametric magnetic resonance imaging to clinical nomograms in predicting adverse pathology in prostate cancer. J Urol 2018 ; 200 : 1041-7.

PubMed

10. Reeves F, et al. Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates : Results of a systematic review and meta-analysis. Eur Urol 2015 ; 68 : 692-704.

 

11. Nguyen LN, et al. The risks and benefits of cavernous neurovascular bundle sparing during radical prostatectomy : A systematic review and meta-analysis. J Urol 2017 ; 198 : 760-9.

PubMed

12. Marenco J, et al. Role of MRI in planning radical prostatectomy : what is the added value? World J Urol 2019 ; 37 : 1289-92.

PubMed

P.130 掲載の参考文献

13. Bach C, et al. The status of surgery in the management of high-risk prostate cancer. Nat Rev Urol 2014 ; 11 : 342-51.

PubMed

14. Saika T, et al. Role of robot-assisted radical prostatectomy in locally advanced prostate cancer. Int J Urol 2018 ; 25 : 30-5.

PubMed

15. Lightfoot AJ, et al. Positive surgical margin trends in patients with pathologic T3 prostate cancer treated with robot-assisted radical prostatectomy. J Endourol 2015 ; 29 : 634-9.

PubMed

P.133 掲載の参考文献

1. Weinreb JC, et al. PI-RADS prostate imaging-Reporting and Data System : 2015, Version 2. Eur Urol 2016 ; 69 : 16-40.

 

2. Turkbey B, et al. Prostate imaging reporting and data system version 2.1 : 2019 update of prostate imaging reporting and data system version 2. Eur Urol 2019 ; 76 : 340-51.

PubMed

P.137 掲載の参考文献

3. Tamada T, et al. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer. Eur J Radiol 2019 ; 121 : 108704.

PubMed

4. Byun J, et al. Direct comparison of PI-RADS version 2 and 2.1 in transition zone lesions for detection of prostate cancer : Preliminary experience. J Magn Reson Imaging 2020 ; 52 : 577-86.

PubMed

P.138 掲載の参考文献

1. Schroder FH, et al. Screening and prostate cancer mortality : results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014 ; 384 : 2027-35.

PubMed

2. 日本泌尿器科学会, 編. 前立腺癌診療ガイドライン 2016年版. メディカルレビュー社, 大阪, 2016, p14-74.

 

3. 日本泌尿器科学会, 編. 前立腺がん検診ガイドライン 2018年版. メディカルレビュー社, 大阪, 2018. p18-82.

 

4. Mottet N, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer 2020. https://uroweb.org/guideline/prostate-cancer/

 

5. Roobol MJ, et al. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators : results from the prostate biopsy collaborative group. World J Urol 2012 ; 30 : 149-55.

 

6. Ito K, et al. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less. Prostate 2003 ; 57 : 8-13.

 

7. Randazzo M, et al. Is further screening of men with baseline PSA < 1 ng ml (-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau). Int J Cancer 2015 ; 137 : 553-9.

 

8. Louie KS, et al. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A metaanalysis. Ann Oncol 2015 ; 26 : 848-64.

PubMed

9. Ahmed HU, et al. Diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer (PROMIS) : a paired validating confirmatory study. Lancet 2017 ; 389 : 815-22.

 

P.139 掲載の参考文献

10. Matsuoka Y, et al. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores : Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol 2020 ; 27 : 760-66.

 

11. Washino S, et al. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients. BJU Int 2017 ; 119 : 225-33.

PubMed

12. Falagario UG, et al. Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning : a retrospective multi-institutional study using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD). Eur Urol Oncol 2020 Sep 21. [Online ahead of print]

 

13. Stevens E, et al. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol 2020 ; 38 : 846. e9-846. e16.

 

P.140 掲載の参考文献

14. Tamada T, et al. Prostate cancer : Diffusion-weighted MR Imaging for detection and assessment of aggressiveness-comparison between conventional and kurtosis models. Radiology 2017 ; 284 : 100-8.

PubMed

15. Tamada T, et al. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1. J Magn Reson Imaging 2020 ; e27283.

 

P.142 掲載の参考文献

16. Moldovan PC, et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? a systematic review and meta-analysis from the European association of urology prostate cancer guidelines panel. Eur Urol 2017 ; 72 : 250-66.

PubMed

17. Borofsky S, et al. What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology 2018 ; 286 : 186-95.

PubMed

18. Panebianco V, et al. Negative multiparametric magnetic resonance imaging for prostate cancer : what's next? Eur Urol 2018 ; 74 : 48-54.

PubMed

19. Yamada K, et al. MRI features of mucinous adenocarcinoma of the prostate : report of four cases. Abdom Radiol (NY) 2019 ; 44 : 1261-8.

PubMed

20. Truong M, et al. Impact of Gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging : correlation with final histopathology. J Urol 2017 ; 198 : 316-21.

PubMed

21. Prendeville S, et al. Role of magnetic resonance imaging targeted biopsy in detection of prostate cancer harboring adverse pathological features of intraductal carcinoma and invasive cribriform carcinoma. J Urol 2018 ; 200 : 104-13.

PubMed

P.143 掲載の参考文献

22. Miyai K, et al. Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer. Mod Pathol 2019 ; 32 : 1536-43.

PubMed

23. Borren A, et al. Accurate prostate tumour detection with multiparametric magnetic resonance imaging : dependence on histological properties. Acta Oncol 2014 ; 53 : 88-95.

PubMed

24. Bjurlin MA, et al. Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer. J Urol 2020 ; 203 : 706-12.

PubMed

25. Tsuzuki T. Intraductal carcinoma of the prostate : a comprehensive and updated review. Int J Urol 2015 ; 22 : 140-5.

PubMed

P.145 掲載の参考文献

26. Tamada T, et al. Prostate cancer : relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008 ; 248 : 531-9.

PubMed

27. Barrett T, et al. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. Radiology 2012 ; 263 : 751-7.

PubMed

P.146 掲載の参考文献

28. Epstein JI, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma : Definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016 ; 40 : 244-52.

PubMed

P.150 掲載の参考文献

29. Suzuki, T., et al. MRI findings of granulomatous prostatitis developing after intravesical Bacillus Calmette-Guerin therapy. Clinical radiology 2013 ; 68 : 595-99.

PubMed

30. Takeuchi M, et al. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Acad Radiol 2012 ; 19 : 827-33.

 

P.152 掲載の参考文献

31. Ahmed HU, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS) : A paired validating confirmatory study. Lancet 2017 ; 389 : 815-22.

 

32. Rosenkrantz AB, et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy : A consensus statement by AUA and SAR. J Urol 2016 ; 196 : 1613-8.

 

33. Kasivisvanathan V, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018 ; 378 : 1767-77.

 

P.154 掲載の参考文献

1. 日本泌尿器科学会, 編. 前立腺癌診療ガイドライン 2016年版. メディカレルビュー社, 大阪, 2016.

 

2. Murphy AM, et al. The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. BJU Int 2010 ; 105 : 176-9.

 

3. Barchetti F, Panebianco V. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int 2014 ; 2014 : 316272.

PubMed

4. Leventis AK, et al. Local recurrence after radical prostatectomy : correlation of US features with prostatic fossa biopsy findings. Radiology 2001 ; 219 : 432-9.

PubMed

P.155 掲載の参考文献

5. Pucar D, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor : magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007 ; 69 : 62-9.

PubMed

6. Kitajima K, et al. Detection of local recurrence of prostate cancer after radical prostatectomy using endorectal coil MRI at 3 T : Addition of DWI and dynamic contrast enhancement to T2-weighted MRI. AJR Am J Roentgenol 2015 ; 205 : 807-16.

PubMed

P.156 掲載の参考文献

7. Tamada T, et al. Locally recurrent prostate cancer after high-dose-rate brachytherapy : the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. AJR Am J Roentgenol 2011 ; 197 : 408-14.

PubMed

8. Nadal R, et al. Small cell carcinoma of the prostate. Nat Rev Urol 2014 ; 11 : 213-9.

PubMed

P.157 掲載の参考文献

1. Gandaglia G, et al. Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur Urol 2015 ; 68 : 325-34.

PubMed

2. Abuzallouf S, et al. Baseline staging of newly diagnosed prostate cancer : a summary of the literature. J Urol 2004 ; 171 : 2122-7.

PubMed

3. K osuda S, et al. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Cancer 2002 ; 94 : 964-72.

 

4. Sweeney CJ, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 2015 ; 373 : 737-46.

PubMed

5. Fizazi K, et al Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med 2017 ; 377 : 352-60.

PubMed

6. Parker CC, et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE) : a randomised controlled phase 3 trial. Lancet 2018 ; 392 : 2353-66.

 

P.160 掲載の参考文献

7. Armstrong AJ, et al. Phase 3 Assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer : A secondary analysis of a randomized clinical trial. JAMA Oncol 2018 ; 4 : 944-51.

PubMed

P.161 掲載の参考文献

8. Even-Spair E, et al. The detection of bone metastases in patients with high-risk prostate cancer : 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006 ; 47 : 287-97.

 

9. Kitajima K, et al : Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer. Nagoya J Med Sci 2017 ; 79 : 387-99.

PubMed

10. Lecouvet FE, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 2012 ; 62 : 68-75.

 

11. Padhani AR, et al. METastasis reporting and data system for prostate cancer : practical guidelines for acquisition, interpretation, and reporting of wholebody magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 2017 ; 71 : 81-92.

PubMed

12. Perez-Lopez R, et al. Volume of bone metastasis assessed with whole-body diffusion-weighted imaging is associated with overall survival in metastatic castration-resistant prostate cancer. Radiology 2016 ; 280 : 151-60.

PubMed

13. Pyka T, et al. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. Eur J Nucl Med Mol Imaging 2016 ; 43 : 2114-21.

PubMed

05 精巣 ( 精嚢 ), 陰茎

P.164 掲載の参考文献

1. Expert Panel on Urological Imaging, et al. ACR Appropriateness Criteria(R) Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass. J Am Coll Radiol 2019 ; 16 : S38-S43.

 

P.166 掲載の参考文献

2. Tsili AC, et al. MRI of the scrotum : Recommendations of the ESUR Scrotal and Penile Imaging Working Group. Eur Radiol 2018 ; 28 : 31-43.

 

P.167 掲載の参考文献

1. Woodward PJ, et al. From the archives of the AFIP extratesticular scrotal masses : Radiologic-pathologic correlation. Radiographics 2003 ; 23 : 215-40.

PubMed

P.168 掲載の参考文献

2. Akbar SA, et al. Multimodality imaging of paratesticular neoplasms and their rare mimics. Radiographics 2003 ; 23 : 1461-76.

PubMed

3. Taghavi K, et al. The bell-clapper deformity of the testis : The definitive pathological anatomy. J Pediatr Surg 2020 ; S0022-3468 (20) 30443-7.

 

P.170 掲載の参考文献

1. 日本小児泌尿器科学会学術委員会, 編.停留精巣診療ガイドライン. 日小児泌会誌 2005 ; 14 : 117-52.

 

2. Walsh TJ, et al. Prepubertal orchidopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 2007 ; 178 : 1440-6.

PubMed

3. Shibata Y, et al. Optimal cutoff value of contralateral testicular size for prediction of absent testis in Japanese boys with nonpalpable testis. Urology 2010 ; 76 : 78-81.

PubMed

P.171 掲載の参考文献

4. Wood HM, et al. Cryptorchidism and testicular cancer : Separating fact from fiction. J Urol 2009 ; 181 : 452-61.

PubMed

5. Krishnaswami S, et al. Magnetic resonance imaging for locating nonpalpable undescended testicles : A meta-analysis. Pediatrics 2013 ; 131 : e1908-16.

PubMed

6. Kato T, et al. Findings of fat-suppressed T2-weighted and diffusion-weighted magnetic resonance imaging in the diagnosis of non-palpable testes. BJU Int 2011 ; 107 : 290-4.

PubMed

P.173 掲載の参考文献

1. Peterson AC, et al. The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old. J Urol 2001 ; 166 : 2061-4.

 

2. Serter S, et al. Prevalence of testicular microlithiasis in an asymptomatic population. Scand J Urol Nephrol 2006 ; 40 : 212-4.

 

3. Miller FN, et al. Testicular calcification and microlithiasis : association with primary intra-testicular malignancy in 3,477 patients. Eur Radiol 2006 ; 17 : 363-9.

PubMed

4. Sakamoto H, et al. Testicular microlithiasis identified ultrasonographically in Japanese adult patients : prevalence and associated conditions. Urology 2006 ; 68 : 636-41.

PubMed

5. 久保裕之, ほか. 小児精巣微小石灰化症の発生頻度とその臨床的検討. 日小外会誌 2014 ; 50 : 884-9.

Medical*Online

6. 前田雄司, ほか. 精巣微小石灰化の臨床病理学的検討. 日泌会誌 2000 ; 91 : 673-8.

 

7. Goede J, et al. Testicular microlithiasis in two boys with a chromosomal abnormality. Indian J Urol 2012 ; 28 : 211-2.

PubMed

8. Xu C, et al. The association between testicular microlithiasis and semen parameters in Chinese adult men with fertility intention : experience of 226 cases. Urology 2014 ; 84 : 815-20.

PubMed

P.174 掲載の参考文献

9. Trout AT, et al. Association between testicular microlithiasis and testicular neoplasia : large multicenter study in a pediatric population. Radiology 2017 ; 285 : 576-83.

 

10. Winter TC, et al. Testicular microlithiasis : What should you recommend? AJR Am J Roentgenol 2016 ; 206 : 1164-9.

PubMed

11. YU CJ, et al. Incidence characteristics of testicular microlithiasis and its association with risk of primary testicular tumors in children : a systematic review and meta-analysis. World J Pediatr 2019 Dec 18. [Epub ahead of print]

 

12. 井原英有, ほか. 精巣微小石灰化症の14例. 泌紀 2003 ; 49 : 575-8.

 

P.175 掲載の参考文献

1. 森永正二郎. 22 精巣・付属器. 外科病理学, 第4版, 向井清, ほか編. 文光堂, 東京, 2006, p961-5.

 

2. 日本泌尿器科学会, ほか編. 精巣腫瘍取扱い規約, 第4版. 金原出版, 東京, 2018.

 

3. Moch H, et al. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th Edition. IARC, Lyon, 2016, p185-258.

 

P.176 掲載の参考文献

4. Williamson SR, et al. The World Health Organization 2016 classification of testicular germ cell tumours : a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology 2017 ; 70 : 335-46.

PubMed

5. 富田圭司, ほか : 精巣癌の発症・進展メカニズム, 日臨 2017 ; 75 (増刊号7) : 366-9.

Medical*Online

P.179 掲載の参考文献

1. Garner MJ,et al. Epidemiology of testicular cancer : An overview. Int J Cancer 2005 ; 116 : 331-9.

PubMed

2. 日本泌尿器科学会, 編. 精巣腫瘍診療ガイドライン, 2015年版. 金原出版, 東京, 2015, p20-2.

 

P.181 掲載の参考文献

1. Moch H, et al. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th Edition. IARC, Lyon, 2016.

 

2. 日本泌尿器科学会/日本病理学会/日本医学放射線学会/日本臨床腫瘍学会, 編. 精巣腫瘍取扱い規約, 第4版. 金原出版, 東京, 2018.

 

3. Tsili AC, et al. MRI of the scrotum : Recommendations of the ESUR Scrotal and Penile Imaging Working Group. Eur Radiol 2018 ; 28 : 31-43.

 

P.183 掲載の参考文献

4. 森山正二郎. パラダイムシフトを迎えた精巣胚細胞腫瘍の概念と分類. 臨泌 2016 ; 70 : 760-7.

 

P.185 掲載の参考文献

1. 江戸博美, ほか. 陰嚢の精巣外腫瘤性病変のMRI. 臨放 2015 ; 60 : 349-59.

 

P.186 掲載の参考文献

2. 佐々木純, ほか. 精巣原発リンパ腫. 血腫瘍 1999 ; 39 : 148-51.

 

3. 河本敦夫, ほか. 陰嚢内容の超音波検査. 超音波医学 2014 ; 41 : 665-73.

Medical*Online

4. Mazzu D, et al. Lymphoma and leukemia involving the testicles : findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol 1995 ; 164 : 645-7.

PubMed

5. Bertolotto M, et al. Grayscale and Color Doppler Features of Testicular lymphoma. J Ultrasound Med 2015 ; 34 : 1139-45.

PubMed

6. Ferry JA, et al. Malignat lymphoma of the testis and spermatic cord. A clinicopathological study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994 ; 18 : 376-90.

 

P.187 掲載の参考文献

7. Finklestein JZ, et al. Leukemic infiltration of the testes during bone marrow remission. Pediatrics 1969 ; 43 : 1042-5.

PubMed

8. Montgomery E, et al. Paratesticular liposarcoma : a clinicopathologic study. Am J Surg Pathol 2003 ; 27 : 40-7.

PubMed

9. Evans HL. Liposarcoma : a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979 ; 3 : 507-23.

PubMed

10. Panzarella MJ, et al. Predictive value of gadolinium enhancement in differentiating ALT/WD liposarcomas from benign fatty tumors. Skeletal Radiol 2005 ; 34 ; 272-8.

PubMed

P.188 掲載の参考文献

11. Yoon Ko, et al. Papillary Cystadenoma of the Epididymis : A Case Report and Review of the Literature. Am J Sonogr 2018 ; 1 : 1-4.

 

12. Alexander JA, et al. Ultrasound demonstration of a papillary cystadenoma of the epididymis. J Clin Ultrasound 1991 ; 19 : 442-5.

 

P.189 掲載の参考文献

1. 河田光博, ほか監訳. 19 男性生殖器系.カラーアトラス機能組織学, 原著第2版. 医歯薬出版, 東京, 2013, p441-67.

 

2. 三浦一陽. 病態と診断. 泌外 2002 ; 15 : 637-40.

Medical*Online

3. Miyamoto T, et al. Human male infertility and its genetic causes. Reprod Med Biol 2017 ; 16 : 81-8.

PubMed

4. Miyamoto T, et al. Male infertility and its genetic causes. J Obstet Gynaecol Res 2015 ; 41 : 1501-5.

PubMed

5. 森永正二郎. 22 精巣・付属器. 外科病理学, 第4版 II. 向井清, ほか編. 文光堂, 東京, 2006, p961-5.

 

P.190 掲載の参考文献

6. Abdullah L, et al. Histopathological patterns of testicular biopsy in male infertility : A retrospective study from a tertiary care center in the western part of Saudi Arabia. Urol Ann 2011 ; 3 : 19-23.

 

7. Johnsen SG. Testicular Biopsy Score Count-A method for registration of spermatogenesis in human testes : Normal values and results in 335 hypogonadal males. Hormones 1970 ; 1 : 2-25.

 

P.191 掲載の参考文献

1. Louis JF, et al. The prevalence of couple infertility in the United States from a male perspective : evidence from a nationality representative sample. Andrology 2013 ; 1 : 741-8.

PubMed

2. 厚生労働省子ども・子育て支援推進調査研究事業 我が国における男性不妊に対する検査・治療に関する調査研究 平成27年度総括・分担研究報告書. 研究代表者 : 湯村寧. 厚生労働省 ; 2016.

 

3. 松田公志, ほか. 小児鼠径ヘルニア手術後の精管閉塞 : 泌尿器科男子不妊外来での経験. 日小外会誌 1991 ; 27 : 35-9.

 

4. 松田公志, ほか. 閉塞性無精子症に対する精路再建術の成績 : 全国多施設での調査報告. 日不妊会誌 2000 ; 45 : 143-9.

 

5. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. World Health Organization. Fertil Steril 1992 ; 57 : 1289-93.

 

6. Jungwirth A, et al. European association of urology guidelines on male infertility : the 2012 update. Eur Urol 2012 ; 62 : 324-32.

PubMed

7. Mordel N, et al. Spermatic vein ligation as treatment for male infertility : justification by post-operative semen improvement and pregnancy rates. J Reprod Med 1990 ; 35 : 123-7.

 

8. Taniguchi H, et al. Contemporary outcomes of seminal tract re-anastomoses for obstructive azoospermia : a nationwide Japanese survey. Int J Urol 2015 ; 2 : 213-8.

PubMed

P.194 掲載の参考文献

1. Hughes IA, et al. Consensus statement on management of intersex disorders. Arch Dis Child 2006 ; 91 : 554-63.

PubMed

2. 日本小児内分泌学会性分化委員会, 編. 性分化異常の管理に関する合意見解. 日小児会誌 2008 ; 112 : 565-78.

 

3. 堀川玲子, 日本小児内分泌学会性分化委員会. 性分化疾患初期対応の手引き. 日小児会誌 2011 ; 115 : 5-12. http://jspe.umin.jp/medical/gui.html

 

P.198 掲載の参考文献

1. Expert Panel on Urological Imaging, et al. ACR Appropriateness Criteria Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass. J Am Coll Radiol 2019 ; 16 : S38-S43.

 

2. Prando D. Torsion of the spermatic cord : the main gray-scale and doppler sonographic signs. Abdom Imaging 2009 ; 34 : 648-61.

PubMed

3. McDowall J, et al. The ultrasonographic "whirlpool sign" in testicular torsion : valuable tool or waste of valuable time? A systematic review and metaanalysis. Emerg Radiol 2018 ; 25 : 281-92.

PubMed

4. Kalfa N, et al. Multicenter assessment of ultrasound of the spermatic cord in children with acute scrotum. J Urol 2007 ; 177 : 297-301.

PubMed

日本泌尿器学会, 編. 急性陰嚢症診療ガイドライン, 2014年版. 金原出版, 東京, 2014.

 

P.200 掲載の参考文献

5. 赤座英之, 監, 並木幹夫, ほか編. 標準泌尿器科学 第9版. 医学書院, 東京, 2014, p102-14.

 

6. Montague DK, et al. Members of the Erectile Dysfunction Guideline Update Panel. American Urological Association guideline on the management of priapism. J Urol 2003 ; 170 : 1318-24.

 

P.202 掲載の参考文献

1. 谷口久哲, ほか. 血精液症. 医事新報 2019 ; 4975 : 42-2.

Medical*Online

2. Furuya S, et al. Hematospermia : an investigation of the bleeding site and underlying lesions. Int J Urol 1999 ; 6 : 539-48.

PubMed

3. Fuse H, et al. Hematospermia : etiology, diagnosis, and treatment. Reprod Med Biol 2011 ; 10 : 153-9.

PubMed

4. 古屋聖兒. たかが血精液症, されど血精液症. 泌紀 2010 ; 23 : 377-81.

 

5. Leary FJ, et al. Clinical significance of hematospermia. Mayo Clin Proc 1974 ; 49 : 815-7.

PubMed

P.203 掲載の参考文献

6. Furuya S, et al. Magnetic resonance imaging is accurate to detect bleeding in the seminal vesicles in patients with hematospermia. Urology 2008 ; 72 : 838-42.

PubMed

06 後腹膜病変

P.207 掲載の参考文献

1. 松永尚文, ほか編. 読影の手立てとなる局所解剖と画像診断. メジカルビュー社, 東京, 2018, p186-217.

 

2. Rajiah P, et al. Imaging of uncommon retroperitoneal masses. Radiographics 2011 ; 31 : 949-76.

PubMed

3. Tirkes T, et al. Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging. Radiographics 2012 ; 32 : 437-51.

PubMed

4. 汲田伸一郎, ほか編. 画像診断のためのリンパ節カラーアトラス. 金原出版, 東京, 2015.

 

P.208 掲載の参考文献

1. Nishino M, et al. Primarily retroperitoneal neoplasms : CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics 2003 ; 23 : 45-57.

 

2. Scali EP, et al. Primarily retroperitoneal masses : what is the differential diagnosis?. Abdom Imaging 2015 ; 40 : 1887-903.

 

P.209 掲載の参考文献

3. 急性膵炎診療ガイドライン2015改訂出版委員会, ほか編. 急性膵炎診療ガイドライン 2015 (第4版). 金原出版, 東京, 2015.

 

P.210 掲載の参考文献

4. 市場文功. 画像による病変の由来部位の診断. 第5章 腹部 1. 上腹部. 画像診断 2017 ; 37増刊号 : 134-49.

 

P.212 掲載の参考文献

5. Yang DM, et al. Retroperitoneal cystic masses : CT, clinical, and pathologic findings and literature review. Radiographics 2004 ; 23 : 1353-65.

 

P.213 掲載の参考文献

6. Fletcher CDM, et al. WHO Classification of Tumours of Soft Tissue and Bone, 4th ed. WHO, Geneve, 2013, p10-1.

 

7. Osman S, et al. A comprehensive review of the retroperitoneal anatomy, neoplasms, and pattern of disease spread. Curr Probl Diagn Radiol 2013 ; 42 : 191-208.

 

8. Rajiah P, et al. Imaging of uncommon retroperitoneal masses. Radiographics 2011 ; 31 : 949-76.

PubMed

P.214 掲載の参考文献

9. Rajiah P, et al. Imaging of uncommon retroperitoneal masses. Radiographics 2011 ; 31 : 949-76.

PubMed

10. Pallisa E, et al. Lymphangio-leiomyomatosis : Pulmonary and abdominal findings with pathologic correlation. Radiographics 2002 ; 22 : 185-98.

 

P.217 掲載の参考文献

1. Yang DM, et al. Retroperitoneal cystic masses : CT, clinical, and pathologic findings and literature review. Radiographics 2004 ; 24 : 1353-65.

PubMed

2. Shaaban AM, et al. Fat-containing retroperitoneal lesions : Imaging characteristicsc, localization, and differential diagnosis. Radiographics 2016 ; 36 : 710-34.

PubMed

P.218 掲載の参考文献

3. McAdams HP, et al. Bronchogenic cyst : imaging features with clinical and histopathologic correlation. Radiology 2000 ; 217 : 441-6.

PubMed

P.219 掲載の参考文献

4. Murakami R, et al. Retroperitoneal bronchogenic cyst : CT and MR imaging. Abdom Imaging 2000 ; 25 : 444-7.

 

5. 急性膵炎診療ガイドライン2015改訂出版委員会, 編. 急性膵炎診療ガイドライン 2015 第4版. 金原出版, 東京, 2015.

 

P.220 掲載の参考文献

6. Hughes MJ, et al : Imaging features of retroperitoneal and pelvic schwannomas. Clin Radiol 2005 ; 60 : 886-93.

PubMed

7. Rajiah P, et al. Imaging of uncommon retroperitoneal masses. Radiographics 2011 ; 31 : 949-76.

PubMed

8. Rha SE, et al. Neurogenic tumors in the abdomen : tumor types and imaging characteristics. Radiographics 2003 ; 23 : 29-43.

PubMed

9. Shanbhogue AK, et al. Uncommon primary pelvic retroperitoneal masses in adults : a pattern-based imaging approach. Radiographics 2012 ; 32 : 795-817.

PubMed

10. Blake MA, et al. Pheochromocytoma : an imaging chameleon. Radiographics 2004 ; 24 (Suppl 1) : S87-99.

 

P.221 掲載の参考文献

11. Kransdorf MJ, et al. Imaging of fatty tumors : distinction of lipoma and well-differentiated liposarcoma. Radiology 2002 ; 224 : 99-104.

PubMed

12. Levy AD, et al. Soft-tissue sarcomas of the abdomen and pelvis : Radiologic-pathologic features, Part 1-Common sarcomas : From the radiologic pathology archives. Radiographics 2017 ; 37 : 462-83.

PubMed

13. Nishino M, et al. Primary retroperitoneal neoplasms : CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics 2003 ; 23 : 45-57.

 

14. Shaaban AM, et al. Fat-containing retroperitoneal lesions : Imaging characteristics, localization, and differential diagnosis. Radiographics 2016 ; 36 : 710-34.

PubMed

P.223 掲載の参考文献

15. Roberts AS, et al. Extramedullary haematopoiesis : radiological imaging features. Clin Radiol 2016 ; 71 : 807-14.

PubMed

P.225 掲載の参考文献

16. Shaaban AM, et al. Fat-containing retroperitoneal lesions : Imaging characteristics, localization, and differential diagnosis. Radiographics 2016 ; 36 : 710-34.

PubMed

17. Rha SE, et al. Neurogenic tumors in the abdomen : tumor types and imaging characteristics. Radiographics 2003 ; 23 : 29-43.

PubMed

18. Shanbhogue AK, et al. Uncommon primary pelvic retroperitoneal masses in adults : a pattern-based imaging approach. Radiographics 2012 ; 32 : 795-817.

PubMed

19. Duffy S, et al. MR imaging of a posterior mediastinal ganglioneuroma : fat as a useful diagnostic sign. AJNR Am J Neuroradiol 2005 ; 26 : 2658-62.

PubMed

20. Blake MA, et al. Pheochromocytoma : an imaging chameleon. Radiographics 2004 ; 24 (Suppl 1) : S87-99.

 

P.228 掲載の参考文献

21. Goenka AH, et al. Imaging of the retroperitoneal. Radiol Clin N Am 2012 ; 50 : 333-55.

PubMed

22. Elias J, et al. Magnetic resonance imaging of the perirenal space and retroperitoneum. Magn Reson Imaging Clin N Am 2019 ; 27 : 77-103.

PubMed

23. 新井冨生, ほか : 粘液産生性腫瘍の病理. 臨画像 2011 ; 27 : 1294-1305.

 

24. Rha SE, et al. Neurogenic tumors in the abdomen : tumor types and imaging characteristics. Radiographics 2003 ; 23 : 29-43.

PubMed

P.229 掲載の参考文献

25. Kransdorf MJ. Benign soft-tissue tumors in a large referral population : distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 1995 ; 164 : 395-402.

 

P.230 掲載の参考文献

26. Guan YB, et al. CT and MRI findings of thoracic ganglioneuroma. Br J Radiol 2012 ; 85 : e365-72.

PubMed

27. 日本病理学会小児腫瘍組織分類委員会, 編. 小児腫瘍組織カラーアトラス 第2巻 神経芽腫群腫瘍-国際分類INPCによる-. 金原出版, 東京, 2004.

 

28. Levy AD, et al. Soft-tissue sarcomas of the abdomen and pelvis : Radiologicpathologic features, part 2- uncommon sarcomas. Radiographics 2017 ; 37 : 797-812.

PubMed

29. Levy AD, et al. Soft-tissue sarcomas of the abdomen and pelvis : Radiologic-pathologic features, part 1- common sarcomas : from the Radiologic pathology archives. Radiographics 2017 ; 37 : 462-83.

PubMed

P.232 掲載の参考文献

30. Neville A, et al. CT characteristics of primary retroperitoneal neoplasms. Crit Rev Comput Tomogr 2004 ; 45 : 247-70.

PubMed

31. Koh DM, et al. Imaging tumours of the retroperitoneum. Imaging 2000 ; 12 : 49-60.

 

32. Zhao S, et al. Imaging and clinical features of Castleman disease. Cancer Imaging 2019 ; 19 : 53.

 

P.234 掲載の参考文献

33. 山田孝之. 後腹膜・躯幹部組織由来の腫瘍性病変 : 特集 胸壁, 後腹膜, 躯幹部組織の解剖と病変の画像診断. 臨画像 2011 ; 27 : 730-45.

 

34. 大杉圭, ほか. 後腹 膜 : 泌尿器・生殖器腫瘍-丸わかり辞典. 臨床画像 2010 ; 26 : 163-200.

 

35. Rajiah P, et al. Imaging of uncommon retroperitoneal masses. Radiographics 2011 ; 31 : 949-76.

PubMed

36. Shanbhogue AK, et al. Uncommon primary pelvic retroperitoneal masses in adults : a pattern-based imaging approach. Radiographics 2012 ; 32 : 795-817.

PubMed

P.236 掲載の参考文献

1. Torigian DA, et al. Retroperitoneum. CT and MRI of the whole body. Haaga JR, et al (eds). Mosby Elsevier, New York, 2000, p484-90.

 

2. Yagan N, et al. Extension of air into the right perirenal space after duodenal perforation : CT findings. Radiology 2009 ; 250 : 740-8.

PubMed

3. Daly KP, et al. Traumatic retroperitoneal injuries : review of multidetector CT findings. Radiographics 2008 ; 28 : 1571-90.

PubMed

P.237 掲載の参考文献

4. 丹野啓介 : 後腹膜・躯幹部組織の解剖と画像. 臨床画像 2011 ; 27 : 711-8.

Medical*Online

5. Orwig D, et al. Localized clotted blood as evidence of visceral trauma on CT : the sentinel clot sign. AJR Am J Roentgenol 1989 ; 153 : 747-9.

 

P.238 掲載の参考文献

6. Tritton RL, et al. Urine leaks and urinomas : diagnosis and Imaging-guided intervention. Radiographics 2003 ; 23 : 1133-47.

 

P.240 掲載の参考文献

7. Martinez-de-Alegria A, et al. IgG4-related disease from head to toe. Radiographics 2015 ; 35 : 2007-25.

PubMed

8. Vaglio A, et al. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol 2016 ; 27 : 1880-9.

PubMed

P.241 掲載の参考文献

9. Diamond EL, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 2014 ; 124 : 483-92.

PubMed

10. Purysko AS, et al. Imaging manifestations of hematologic diseases with renal and perinephric involvement. Radiographics 2016 ; 36 : 1038-54.

PubMed

P.244 掲載の参考文献

11. 里上直衛, ほか. Erdheim-Chester病-Erdheim-Chester diseaseと冠動脈狭窄を伴わない心周囲腫瘤. この画像を見たらほぼ決まり! パターン認識からのアプローチ. 画像診断 2012 ; 32 (4月臨時増刊号) : s164-5.

 

12. Barra F, et al. Ureteral endometriosis : a systematic review of epidemiology, pathogenesis, diagnosis, treatment, risk of malignant transformation and fertility. Hum Reprod Update 2018 ; 24 : 710-30.

PubMed

P.245 掲載の参考文献

1. Patel IJ, et al. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II : Recommendations : Endorsed by the Canadian Association for Interventional adiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 2019 ; 30 : 1168-84.

 

平木隆夫, ほか. CTガイド下穿刺. 救急IVR手技詳説. 臨放 2018 ; 63 (臨時増刊号) : 1578-81.

 

07 小児

P.248 掲載の参考文献

1. Young AS, et al. Genitourinary diagnostic procedure. Caffey's pediatric diagnostic imaging 11 ed. Slovis TL, ed. Mosby, Philaderphia, 2008, p1785-804.

 

2. Ntoulia A, et al. Diagnostic procedures : excluding MRI, Nuclear Medicine and video urodynamics. Pediatric Urogenital radiology, Riccabona M, ed. Springer, Netherlands, 2018, p3-32.

 

3. Darge K, et al. Urinary tract. Pediatric sonography 5th ed, Siegel MJ, ed. Wolters Kluwer, Philaderphia, 2019, p396-466.

 

P.249 掲載の参考文献

4. Daneman A, et al. Renal pyramids : focused sonography of normal and pathologic processes. Radiographics 2010 ; 30 : 1287-307.

PubMed

5. Ramanathan S, et al. Multi-modality imaging review of congenital abnormalities of kidney and upper urinary tract. World J Radiol 2016 ; 8 : 132-41.

PubMed

6. Washburn ZW, et al. Computed tomographic urography update : An evolving urinary tract imaging modality. Semin Ultrasound CT MRI 2009 ; 30 : 233-45.

 

7. Grattan-Smith JD, et al. MR of the urogenital tract in children. Pediatric urogenital radiology, 3rd ed. Springer, Netherlands, 2018, p33-91.

 

8. Vivier PH, et al. MRI and suspected acute pyelonephritis in children : comparison of diffusion-weighted imaging with gadolinium-enhanced T1-weighted imaging. Eur Radiol 2014 ; 24 : 19-25.

 

9. Gawande RS, et al. Role of diffusion-weighted imaging in differentiating benign and malignant pediatric abdominal tumors : Pediatr Radiol 2013 ; 43 : 836-45.

PubMed

P.250 掲載の参考文献

10. Dacher JN. Diagnositc procudures excluding MRI, Nuclear medicine and video-urodynamics. Pediatric uroradiology, 2nd ed, Fotter R, ed. Springer, Heidelberg, 2008, p1-15.

 

P.251 掲載の参考文献

11. Easty M, et al. Nuclear Medicin. Pediatric urogenital radiology, 3rd ed, Riccabona M, ed. Springer, Netherlands, 2018, p93-116.

 

12. 島田憲次, ほか. 周産期, 乳幼児期に発見される腎盂・腎盂尿管拡張の診断基準 (案), 利尿レノグラフィ実施のための標準プロトコール. 日小児泌会誌 1999 ; 8 : 186-9.

 

13. 白柳慶之, ほか. CAKUT (congenital anomalies of the kidney and urinary tract) に対する画像検査-排尿時膀胱尿道造影 (VCUG) と日小児腎臓病会誌. 日児腎誌 2015 ; 26 : 33-42.

 

P.252 掲載の参考文献

1. 赤坂好宣, ほか. 腎・尿管 : 先天異常. 小児超音波診断のすべて. メジカルビュー社, 東京, 2015, p480-502.

 

2. 赤坂好宣. 小児先天性疾患に強くなる : 泌尿生殖器. 画像診断 2011 ; 31 : 590-602.

 

3. 島田憲次. 泌尿器生殖器. 標準小児外科学, 第5版, 伊藤泰雄, ほか編. 医学書院, 東京, 2007, p270-90.

 

P.256 掲載の参考文献

1. RIVUR Trial Investigators ; Hoberman A, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014 ; 370 : 2367-76.

PubMed

2. Montini G, et al. Value of imaging studies after a first febrile urinary tract infection in young children : data from Italian renal infection study 1. Pediatrics 2009 ; 123 : e239-46.

PubMed

小児膀胱尿管逆流 (VUR) 診療手引き 2016. https://jspu.jp/download/guideline/tebiki2016-2.pdf

 

JAID/JSC感染症治療ガイドライン 2015-尿路感染症・男性性器感染症-. https://www.chemotherapy.or.jp/guideline/jaidjsckansenshochiryo_nyouro.pdf

 

American College of Radiology. ACR Appropriateness Criteria(R) Urinary Tract Infection-Child. https://acsearch.acr.org/docs/69444/Narrative/

 

Stein R, et al. Urinary tract infections in children : EAU/ESPU guidelines. Eur Urol 2015 ; 67 : 546-58.

PubMed

P.257 掲載の参考文献

3. Stein R, et al. Urinary tract infections in children : EAU/ESPU guidelines. Eur Urol 2015 ; 67 : 546-58.

PubMed

4. Lebowitz RL, et al. International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 1985 ; 15 : 105-9.

PubMed

P.258 掲載の参考文献

5. Benador D, et al. Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet 1997 ; 349 : 17-9.

PubMed

6. Hewitt IK, et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring : data from the Italian Renal Infection Study Trials. Pediatrics 2008 ; 122 : 486-90.

PubMed

P.259 掲載の参考文献

1. Parada Villavicencio C, et al. Imaging of the urachus : anomalies, complications, and mimics. Radiographics 2016 ; 36 : 2049-63.

PubMed

2. Yu JS, et al. Urachal remnant diseases : spectrum of CT and US findings. Radiographics 2001 ; 21 : 451-61.

PubMed

P.260 掲載の参考文献

3. Rafal RB, et al. Urachal carcinoma : the role of magnetic resonance imaging. Urol Radiol 1991 ; 12 : 184-7.

PubMed

P.261 掲載の参考文献

4. Cacciarelli AA, et al. Urachal remnants : sonographic demonstration in children. Radiology 1990 ; 174 : 473-5.

PubMed

5. Paul T Bunch,et al. Allantoic cyst : a prenatal clue to patent urachus. Pediatr Radiol 2006 ; 36 : 1090-5.

PubMed

P.262 掲載の参考文献

1. Davidson AJ, et al. Radiological anatomy of the kidney and ureter. Sanders, Philadelphia, 1994, p53-64.

 

2. Beckwith JB, et al. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990 ; 10 : 1-36.

PubMed

3. Kaneko Y, et al. A high incidence of WT1 abnormality in bilateral Wilms tumors in Japan, and the penetrance rates in children with WT1 germline mutation. Br J Cancer 2015 ; 112 : 1121-33.

 

P.263 掲載の参考文献

4. Anand R, et al. Imaging spectrum of primary malignant renal neoplasms in children. Indian J Med Paediatr Oncol 2012 ; 33 : 242-9.

PubMed

5. Davidoff AM. Wilms tumor. Adv Pediatr 2012 ; 59 : 247-67.

PubMed

P.264 掲載の参考文献

6. Broecker B. Non-Wilms'renal tumors in children. Urol Clin North Am 2000 ; 27 : 463-9.

PubMed

7. Kembhavi S, et al. Paediatric renal tumors with subcapsular fluid sign : Is it specific for rabdoid tumors. OMICS J Radiology 2013 ; 2 : 128.

 

P.265 掲載の参考文献

8. Bolande RP, et al. Congenital mesoblastic nephroma of infancy. Pediatrics 1967 ; 40 : 272-8.

PubMed

9. Joshi VV, Beckwith JB. Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis. Cancer 1989 ; 64 : 466-79.

PubMed

P.266 掲載の参考文献

1. 赤坂好宣, ほか. 金川公夫, ほか編. 腎・尿管 : 先天異常, 小児超音波診断のすべて. メジカルビュー社, 東京, 2015, p480-502.

 

2. 赤坂好宣. 小児先天性疾患に強くなる : 泌尿生殖器. 画像診断 2011 ; 31 : 590-602

 

3. 山下康行. 泌尿器の発生. 知っておきたい泌尿器のCT・MRI 改訂第2版. 山下康行, 編. 学研メディカル秀潤社, 東京, 2019, p446-7.

 

P.267 掲載の参考文献

4. Bedard MP, et al : Embryology, anatomy, and variants of the genitourinary tract. Caffey's pediatric diagnostic imaging. 12th ed. Coley BD, ed. Elsevier Saunders, Philadelphia, 2013. p1163-73.

 

P.270 掲載の参考文献

1. Shimada H, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors : a report from the Children's Cancer Group. Cancer 2001 ; 92 : 2451-61.

 

2. Cohn SL, et al. INRG Task Force : The International Neuroblastoma Risk Group (INRG) classification system : an INRG report. J Clin Oncol 2009 ; 27 : 289-97.

PubMed

3. Brisse HJ, et al. International Neuroblastoma Risk Group Project : Guidelines for imaging and staging of neuroblastic tumors : consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011 ; 261 : 243-57.

PubMed

4. B rodeur GM, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993 ; 11 : 1466-77.

 

5. Park JR, et al. Revisions to the international neuroblastoma response criteria : A consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol 2017 ; 35 : 2580-7.

 

6. 家原知子, ほか. 第6章 神経芽腫. 小児がん診療ガイドライン 2016年版. 日本小児血液・がん学会, 編. 金原出版, 東京, 2016, p199-249.

 

P.275 掲載の参考文献

1. Avni FE, et al. Imaging and classification of congenital cystic renal diseases. AJR Am J Roentgenol 2012 ; 198 : 1004-13.

PubMed

2. Osathanondh V, et al. Pathogenesis of polycystic kidneys. Historical survey. Arch Pathol 1964 ; 77 : 459-65.

PubMed

3. Avni FE, et al. Renal cystic diseases in children : new concepts. Pediatr Radiol 2010 ; 40 : 939-46.

PubMed

4. Devlin LA, et al. Renal ciliopathies. Curr Opin Genet Dev 2019 ; 56 : 49-60.

PubMed

5. Gubler MC. Renal tubular dysgenesis. Pediatr Nephrol 2014 ; 29 : 51-9.

PubMed

6. 金川公夫, ほか, 編. 小児超音波診断のすべて. メジカルビュー社, 東京, 2015, p480-536.

 

7. Pirson Y. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010 ; 17 : 173-80.

PubMed

8. Krishnappa V, et al. Autosomal dominant polycystic kidney disease and the heart and brain. Cleve Clin J Med 2017 ; 84 : 471-81.

PubMed

P.276 掲載の参考文献

9. Eickmeyer AB, et al. The natural history of the multicystic dysplastic kidney-is limited follow-up warranted? J Pediatr Urol 2014 ; 10 : 655-61.

PubMed

P.278 掲載の参考文献

1. 日本小児泌尿器科学会学術委員会, 編. 小児先天性水腎症 (腎盂尿管移行部通過障害) 診療手引き 2016. 日本小児泌尿器科学会, 2016.

 

2. 林祐太郎. 水腎症の成因. 小児外科 2003 ; 35 : 1021-6.

 

3. 赤坂好宣. 腎・尿路の奇形. 画像診断 2004 ; 24 : 831-41.

 

4. 桑島成子 : 水腎症の診断. 小児外科 2003 ; 35 : 1027-33.

 

5. Cassart M, et al. Prenatal evaluation and postnatal follow-up of ureteral ectopic insertion in multicystic kidneys. Fetal Diagn Ther 2019 ; 45 : 373-80.

PubMed

6. 中井秀郎. 泌尿器・生殖器. 標準小児外科学 第6版. 伊藤泰雄, 監. 医学書院, 東京, 2012, p271-8.

 

7. Dillman FR, et al. Upper urinary tract duplication. Caffey's Pediatric Diagnostic Imaging. 13th ed. Coley BD, ed. Elsevier, Philadelphia, 2019, p1090-104.

 

8. 森義則, ほか. 小児異所開口尿管54例の臨床検討. 日泌尿会誌 2001 ; 92 : 470-3.

 

9. 桑島成子. 胎児MRIの適応と安全. 日磁気共鳴医会誌 2019 ; 39 : 39-47.

 

P.280 掲載の参考文献

10. 河野寿夫. 肺低形成の概念・疫学. 周産期医学 2005 ; 35 : 165-8.

 

11. Curry CJ, et al. The potter sequence : A clinical analysis of 80 cases. Am J Med Genet 1984 ; 19 : 679-702.

 

12. Abe Y, et al. Potter sequence complicated by congenital cystic lesion of the bladder. Am J Perinatol 2002 ; 19 : 267-72.

 

13. 桑島成子. 胎児の画像診断. 画像診断 2014 ; 34 : 1644-55.

Medical*Online

14. Plazanet C, et al. Fetal renin-angiotensin-system blockade syndrome : renal lesions. Pediatr Nephrol 2014 ; 29 : 1221-30.

PubMed

15. Kuwashima S, et al. Low-intensity fetal lungs on MRI may suggest the diagnosis of pulmonary hypoplasia. Pediatr Radiol 2001 ; 31 : 669-72.

PubMed

P.281 掲載の参考文献

16. Savelli S, et al. MRI with diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) assessment in the evaluation of normal and abnormal fetal kidneys : preliminary experience. Prenat Diagn 2007 ; 27 : 1104-11.

PubMed

17. Brewerton LJ, et al. Fetal lung-toliver signal intensity ratio at MR imaging : development of a normal scale and possible role in predicting pulmonary hypoplasia in utero. Radiology 2005 ; 235 : 1005-10.

 

18. Oka Y, et al. Prenatal diagnosis of fetal respiratory function : evaluation of fetal lung maturity using lung-to-liver signal intensity ratio at magnetic resonance imaging. Prenat Diagn 2014 ; 34 : 1289-94.

PubMed

19. Deshmukh S, et al. MR assessment of normal fetal lung volumes : a literature review. AJR Am J Roentgenol 2010 ; 194 : W212-7.

PubMed

P.282 掲載の参考文献

20. Lim FF, et al. Multicystic dysplastic kidney disease presenting with a single large cyst in a fetus-anatomical basis and radiological aspects. Pediatr Neonatol 2011 ; 52 : 227-31.

 

21. Ji H, et al. Magnetic resonsnce imaging for evaluation of foetal multicystic dysplastic kidney. Eur J Radiol 2018 ; 108 : 128-32.

 

22. Gimpel C, et al. Imaging of kidney cysts and cystic kidney diseases in children : An international working group Consensus statement. Radiology 2019 ; 290 : 769-82.

 

23. Onur MR, et al. Cystic abdominal masses in children ; a pictorial essay. Clin Imaging 2013 ; 37 : 18-27.

PubMed

P.284 掲載の参考文献

24. Jeon A, et al. A spectrum of segmental multicystic renal dysplasia. Pediatr Radiol 1999 ; 29 : 309-15.

 

P.285 掲載の参考文献

25. Chauvin NA, et al. Complex genitourinary abnormalities on fetal MRI : imaging findings and approach to diagnosis. AJR Am J Roentgenol 2012 ; 199 : W222-31.

PubMed

26. Calvo-Garcia MA, et al. Fetal MRI clues to diagnose cloacal malformations. Pediatr Radiol 2011 ; 41 : 1117-28.

PubMed

27. Fayard C, et al. AIRP best cases in radiologic-pathologic correlation : prenatal and postmortem imaging of a complex cloacal malformation. Radiographics 2014 ; 34 : 2056-63.

PubMed

28. Sahinoglu Z, et al. Diagnostic difficulties in a case of persistent cloaca with hydrocolpos. J Neonatal Surg 2012 ; 1 : 55.

 

29. Dannull K, et al. Cloacal dysgenesis diagnosis by prenatal ultrasound and MRI. Pediatr Radiol 2014 ; 44 : 230-3.

PubMed

P.286 掲載の参考文献

30. Liu YP, et al. Fetal MRI of hydrometrocolpus with septate vagina and uterus didelphys as well as massive urinary ascites due to cloacal malformation. Pediatr Radiol 2009 ; 39 : 877.

PubMed

31. Perio JL, et al. Prenatal diagnosis of cloacal malformation. Semin Pediatr Surg 2016 ; 25 : 71-5.

 

P.288 掲載の参考文献

1. 金川公夫. 正常像と描出に必要なテクニック 泌尿器腎臓・尿管・尿道・膀胱. 小児超音波診断のすべて. 金川公夫, ほか編. メジカルビュー社, 東京, 2015, p118-29.

 

2. Paltiel HJ, et al. The pediatric urinary tract and adrenal glands. Diagnostic Ultrasound. 5th edition, Rumack CM, et al, eds. Elsevier, Philadelphia, 2018, p1781-5.

 

3. Weinberg K, et al. Urinary system. Textbook of diagnostic sonography. 8th edition, Sandra L, et al, eds. Elsevier, Philadelphia, 2018, p375-431.

 

4. 宮坂実木子, ほか. 知っていると役立つ小児画像診断における正常と異常の境界 : 泌尿器-正常亜型を中心に-. 画像診断 2019 ; 39 : 1579-90.

 

5. 入江健夫, ほか. 臓器・疾患別アプローチ-ワンポイントレクチャー <腎 (解剖と破格) > dromedary hump (ひとこぶ駱駝のこぶ). Medicina 2004 ; 41 : 244

 

P.289 掲載の参考文献

6. 赤坂好宣, ほか. 各疾患の超音波診断のポイントと所見 泌尿器腎・尿管先天異常. 小児超音波診断のすべて, 金川公夫, ほか編. メジカルビュー社, 東京, 2015, p480-502.

 

7. Gary C, et al. Development of the urinary system. Larsen's Human Embryology, fifth edition. Gary C, et al, eds. Elsevier, Philadelphia, 2015, p375-93.

 

書評を投稿する